|
Read the FDA's Warning here.
The
announcement comes just after a
delay of the National
Breastfeeding Awareness Campaign
by formula companies.
Read more here. And
read 20/20's news story about
the "battle between Mother's
Milk and corporate power" here.
Read Dr. Hale's
response here.
(Dr. Hale writes the physician's
resource for drug use and safety
during lactation,
Medications and Mothers' Milk.
He is the recognized
authority in the nation,
possibly the world, on the
subject. Ask your
pharmacist or doctor if
something is safe while
breastfeeding, and she will
consult Dr. Hale's book.)
Here is an
excerpt: "Unfortunately,
the correlation of intravenous
administration with oral
administration of Domperidone is
simply ludicrous...Domperidone
has been used world-wide for
many years with an excellent
safety record. It is approved
for use in all the worlds
largest and finest countries,
including England, Australia,
Canada, etc. This warning from
the FDA has nothing to do with
its safety, its all about the
importation of drugs from Canada
and control by this federal
agency. They simply want to stop
the importation of all drugs,
particularly those used by the
elderly, and now the
breastfeeding mother...The
reality is that I still believe
Domperidone is the safest
product we can use for
stimulating milk production in
some women. It is still true
that in many mothers it offers
the only hope for maintaining a
milk supply for their infants
and preventing the untoward
effects of formula."
Read Dr. Jack Newman's handout
on Domperidone. Dr.
Jack Newman is one of the top
recognized authorities on all
things breastfeeding related in
the US.
Domperidone is approved for use
in breastfeeding mothers by the
AAP (American Academy of
Pediatrics). Reglan is
not.
Find the full list here.
And find more info on
the safety of each and the AAP's
approval here.
Lastly, to put another nail in
the coffin of the FDA on this
matter,
formula manufacturer Wyeth is
also the manufacturer of Reglan,
Domperidone's direct competitor
in the US and the reason
Domperidone has not been pushed
through the FDA's system for
approval. Wyeth apparently
has a bad record as far as
strong arm tactics: "The
benchmark standards for
measuring marketing practices
are the International Code of
Marketing of Breastmilk
Substitutes and relevant World
Health Assembly (WHA)
resolutions...Wyeth has had a
few brushes with national
authorities on code matters."
http://www.ibfan.org/english/pdfs/btr04summary.pdf
I urge you to write to your
congressional representative and
the FDA itself. Contact
information is below. |